XML 56 R43.htm IDEA: XBRL DOCUMENT v3.26.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Amounts related to cumulative basis adjustments for fair value hedges
At March 31, 2026 and December 31, 2025, the following amounts were recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:
($ in millions)March 31,
2026
December 31,
2025
Short-term debt:  
Carrying amount of the hedged item$(493)$— 
Cumulative hedging adjustments included in the carrying amount — assets/(liabilities) — 
Long-term debt:  
Carrying amount of the hedged item(6,136)(6,656)
Cumulative hedging adjustments included in the carrying amount — assets/(liabilities) (1)
58 36 
(1)Includes $(107) million and $(114) million of hedging adjustments on discontinued hedging relationships at March 31, 2026 and December 31, 2025, respectively.
Effect of derivative instruments in the Consolidated Income Statement
The total effect of fair value hedges, cash flow hedges, net investment hedges and derivatives not designated as hedging instruments are summarized by income and expense line items as follows:
($ in millions)
(Gains)/Losses of Total Hedge Activity
Three Months Ended March 31,20262025
Cost of services$15 $
Cost of sales(1)(8)
Cost of financing(1)
SG&A expense67 31 
Other (income) and expense (1)
423 (442)
Interest expense(5)(2)
(1)Primarily driven by currency gains and losses on the company's foreign currency derivatives hedging programs. Refer to note 6, "Other (Income) and Expense," for additional information.
(Gains)/Losses Recognized in Consolidated Income Statement
($ in millions)Consolidated
Income Statement
Line Item
Recognized on
Derivatives
Attributable to Risk
Being Hedged (1)
For the three months ended March 31:2026202520262025
Derivative instruments in fair value hedges: (2)
     
Interest rate contractsCost of financing$$(11)$(5)$14 
Interest expense30 (59)(23)72 
Derivative instruments not designated as hedging instruments: 
Foreign exchange contractsOther (income) and expense103 (120)  N/A N/A
Equity contracts
SG&A expense66 34   N/A N/A
Total $206 $(156)$(29)$86 
Effects of Derivatives Recognized in Consolidated Income Statement and OCI
(Gains)/Losses
($ in millions)
Gains/(Losses) Recognized in OCI
Consolidated
Income Statement
Line Item
Reclassified
from AOCI
Amounts Excluded from
Effectiveness Testing (3)
For the three months ended March 31:202620252026202520262025
Derivative instruments in cash flow hedges:       
Interest rate contracts$— $— Cost of financing$$N/AN/A
Interest expenseN/AN/A
Foreign exchange contracts
Amount included in the assessment of effectiveness(129)42 Cost of services15 N/AN/A
Cost of sales(1)(8)N/AN/A
Cost of financingN/AN/A
SG&A expense(3)N/AN/A
Other (income) and expense289 (348)N/AN/A
Interest expenseN/AN/A
Amount excluded from the assessment of effectiveness(46)(101)Other (income) and expense N/A N/A32 26 
Instruments in net investment hedges: (4)
Foreign exchange contracts
Amount included in the assessment of effectiveness450 (820)
Amount excluded from the assessment of effectiveness14 12 Cost of financing N/A N/A(4)(4)
Interest expense N/A N/A(18)(22)
Total$289 $(867) $311 $(350)$10 $
(1)The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.
(2)The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.
(3)Amounts excluded from effectiveness testing for both net investment hedges and cash flow hedges of foreign currency debt are amortized to net income on a straight line basis over the life of the relevant hedging instrument.
(4)Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.
N/A - not applicable